ALS/FTD-associated FUS activates GSK-3β to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations

Radu Stoica1, Sébastien Paillusson1, Patricia Gomez-Suaga1

  • 1Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.

EMBO Reports
|July 16, 2016
PubMed

Insights

Defective FUS protein disrupts connections between the endoplasmic reticulum and mitochondria, impairing cell function and potentially leading to amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). This disruption affects calcium signaling and ATP production, implicating GSK-3β in the disease process.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Defective FUS (fused in sarcoma) protein metabolism is linked to amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD).
  • Endoplasmic reticulum (ER) and mitochondria signaling, crucial for cellular functions disrupted in ALS/FTD, relies on physical organelle associations.
  • These associations are mediated by the VAPB-PTPIP51 scaffold, tethering ER and mitochondria.

Purpose of the Study:

  • To investigate the role of FUS in disrupting ER-mitochondria communication.
  • To understand the downstream effects of FUS-induced organelle uncoupling on cellular functions.
  • To explore the link between FUS, ER-mitochondria signaling, and ALS/FTD-associated kinases.

Main Methods:

  • Cellular models expressing FUS.
  • Assessment of VAPB-PTPIP51 interaction and ER-mitochondria contacts.
  • Measurement of mitochondrial calcium (Ca2+) uptake and ATP production.
  • Analysis of glycogen synthase kinase-3β (GSK-3β) activation.

Main Results:

  • FUS disrupts the VAPB-PTPIP51 interaction, reducing ER-mitochondria associations.
  • FUS expression impairs mitochondrial Ca2+ uptake and ATP production.
  • FUS-induced reduction in ER-mitochondria contacts correlates with GSK-3β activation.

Conclusions:

  • FUS directly interferes with the physical and functional links between ER and mitochondria.
  • Disruption of ER-mitochondria signaling by FUS contributes to cellular dysfunction relevant to ALS/FTD.
  • FUS-mediated alterations in organelle communication are linked to GSK-3β, a key kinase in ALS/FTD pathogenesis.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
19.3K
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
4.1K
Coat Assembly and GTPases01:33

Coat Assembly and GTPases

Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
4.7K